NCT03618784 Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE1/PHASE2
NCT03617250 Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT03616158 Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over Time Status UNKNOWN Phase N/A
NCT03606876 Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03605251 Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis. Status COMPLETED Phase PHASE2
NCT03604406 The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept Status COMPLETED Phase PHASE2
NCT03593837 Efficacy and Safety of HQGZWWT Patients With Rheumatoid Arthritis Status UNKNOWN Phase PHASE2/PHASE3
NCT03574545 Study Comparing Two VAY736 Drug Products in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT03559686 Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA) Status NO_LONGER_AVAILABLE Phase N/A
NCT03555240 Regional Registry-based Biobank Development and Pharmacogenetic Analysis in Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT03535402 Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics Status UNKNOWN Phase PHASE3
NCT03533569 Early Biomarkers for ARthritic PAIN to Guide Improved Treatments for Arthritis Status UNKNOWN Phase N/A
NCT03514355 MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms Status COMPLETED Phase NA
NCT03511625 The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis Status ACTIVE_NOT_RECRUITING Phase PHASE3